{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:57:50Z","timestamp":1785787070451,"version":"3.56.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Currently, we suffer from an increasing diabetes pandemic and on the other hand from the SARS-CoV-2 pandemic. Already at the beginning of the SARS-CoV-2 pandemic, it was quickly assumed that certain groups are at increased risk to suffer from a severe course of COVID-19. There are serious concerns regarding potential adverse effects on maternal, fetal, and neonatal outcomes. Diabetic pregnancies clearly need special care, but clinical implications as well as the complex interplay of diabetes and SARS-CoV-2 are currently unknown. We summarized the evidence on SARS-CoV-2 in diabetic pregnancies, including the identification of novel potential pathophysiological mechanisms and interactions as well as clinical outcomes and features, screening, and management approaches.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We carried out a systematic scoping review in MEDLINE (PubMed), EMBASE, CINAHL, Cochrane Library, and Web of Science Core Collection in September 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that the prognosis of pregnant women with diabetes mellitus and COVID-19 may be associated with potential underlying mechanisms such as a simplified viral uptake by ACE2, a higher basal value of pro-inflammatory cytokines, being hypoxemic as well as platelet activation, embolism, and preeclampsia. In the context of \u201ctrans-generational programming\u201d and COVID-19, life-long consequences may be \u201cprogrammed\u201d during gestation by pro-inflammation, hypoxia, over- or under-expression of transporters and enzymes, and epigenetic modifications based on changes in the intra-uterine milieu. COVID-19 may cause new onset diabetes mellitus, and that vertical transmission from mother to baby might be possible.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Given the challenges in clinical management, the complex interplay between COVID-19 and diabetic pregnancies, evidence-based recommendations are urgently needed. Digital medicine is a future-oriented and effective approach in the context of clinical diabetes management. We anticipate our review to be a starting point to understand and analyze mechanisms and epidemiology to most effectively treat women with SARS-COV-2 and diabetes in pregnancy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-03975-3","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T23:07:03Z","timestamp":1629500823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["SARS-CoV-2 in diabetic pregnancies: a systematic scoping review"],"prefix":"10.1186","volume":"21","author":[{"given":"Claudia","family":"Eberle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamarra","family":"James-Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Stichling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"key":"3975_CR1","unstructured":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard: Data last updated: 2020\/12\/9, 9:34am CET. 2020. https:\/\/covid19.who.int\/. Accessed 9 Dec 2020."},{"key":"3975_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","volume":"20","author":"R Verity","year":"2020","unstructured":"Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20:669\u201377. https:\/\/doi.org\/10.1016\/S1473-3099(20)30243-7.","journal-title":"Lancet Infect Dis"},{"key":"3975_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11428-020-00611-0","volume":"16","author":"H Kleinwechter","year":"2020","unstructured":"Kleinwechter H, Laubner K. Coronavirus disease 2019 (COVID-19) and pregnancy: Overview and report of the first German case with COVID-19 and gestational diabetes. Diabetologe. 2020;16:242\u20136. https:\/\/doi.org\/10.1007\/s11428-020-00611-0.","journal-title":"Diabetologe"},{"key":"3975_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2020.06.213","author":"KT Bajgain","year":"2020","unstructured":"Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am J Infect Control. 2020. https:\/\/doi.org\/10.1016\/j.ajic.2020.06.213.","journal-title":"Am J Infect Control"},{"key":"3975_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/uog.22006","volume":"55","author":"H Yang","year":"2020","unstructured":"Yang H, Wang C, Poon LC. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol. 2020;55:435\u20137. https:\/\/doi.org\/10.1002\/uog.22006.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3975_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5935\/1518-0557.20200057","volume":"24","author":"G Bahadur","year":"2020","unstructured":"Bahadur G, Homburg R, Yoong W, Singh C, Bhat M, Kotabagi P, et al. Adverse outcomes in SAR-CoV-2 (COVID-19) and SARS virus related pregnancies with probable vertical transmission. JBRA Assist Reprod. 2020;24:351\u20137. https:\/\/doi.org\/10.5935\/1518-0557.20200057.","journal-title":"JBRA Assist Reprod"},{"key":"3975_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s11428-020-00629-4","volume":"16","author":"H Kleinwechter","year":"2020","unstructured":"Kleinwechter H. Diabetes and pregnancy\u2014update 2020. Diabetologe. 2020;16:470\u20137. https:\/\/doi.org\/10.1007\/s11428-020-00629-4.","journal-title":"Diabetologe"},{"key":"3975_CR8","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 9th edition 2019. 2020. https:\/\/www.diabetesatlas.org\/en\/resources\/. Accessed 25 Jun 2020."},{"key":"3975_CR9","unstructured":"World Health Organization. Diabetes. Fact sheet. 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes. Accessed 31 Aug 2020."},{"key":"3975_CR10","unstructured":"German Diabetes Association. Deutscher Gesundheitsbericht Diabetes 2020: Kirchheim + Co GmbH; 2020."},{"key":"3975_CR11","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. Worldwide toll of diabetes. 2020. https:\/\/www.diabetesatlas.org\/en\/sections\/worldwide-toll-of-diabetes.html. Accessed 31 Aug 2020."},{"key":"3975_CR12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43:S14\u201331. https:\/\/doi.org\/10.2337\/dc20-S002.","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"3975_CR13","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.2337\/dc07-s206","volume":"30","author":"A Ferrara","year":"2007","unstructured":"Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(Suppl 2):S141\u20136. https:\/\/doi.org\/10.2337\/dc07-s206.","journal-title":"Diabetes Care"},{"key":"3975_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Zhang C. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr Diab Rep. 2016;16:7. https:\/\/doi.org\/10.1007\/s11892-015-0699-x.","journal-title":"Curr Diab Rep"},{"key":"3975_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40618-016-0607-5","volume":"40","author":"E Chiefari","year":"2017","unstructured":"Chiefari E, Arcidiacono B, Foti D, Brunetti A. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017;40:899\u2013909. https:\/\/doi.org\/10.1007\/s40618-016-0607-5.","journal-title":"J Endocrinol Invest"},{"key":"3975_CR16","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","volume":"373","author":"L Bellamy","year":"2009","unstructured":"Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (London, England). 2009;373:1773\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(09)60731-5.","journal-title":"Lancet (London, England)"},{"key":"3975_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jama.2009.201","volume":"301","author":"KB Kozhimannil","year":"2009","unstructured":"Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA. 2009;301:842\u20137. https:\/\/doi.org\/10.1001\/jama.2009.201.","journal-title":"JAMA"},{"key":"3975_CR18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1097\/GRF.0b013e31815a61d6","volume":"50","author":"BE Metzger","year":"2007","unstructured":"Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol. 2007;50:972\u20139. https:\/\/doi.org\/10.1097\/GRF.0b013e31815a61d6.","journal-title":"Clin Obstet Gynecol"},{"key":"3975_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00125-010-2008-1","volume":"54","author":"NA West","year":"2011","unstructured":"West NA, Crume TL, Maligie MA, Dabelea D. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia. 2011;54:504\u20137. https:\/\/doi.org\/10.1007\/s00125-010-2008-1.","journal-title":"Diabetologia"},{"key":"3975_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1542\/peds.2008-0158","volume":"122","author":"WH Tam","year":"2008","unstructured":"Tam WH, Ma RCW, Yang X, Ko GTC, Tong PCY, Cockram CS, et al. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics. 2008;122:1229\u201334. https:\/\/doi.org\/10.1542\/peds.2008-0158.","journal-title":"Pediatrics"},{"key":"3975_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/BF03373173","volume":"152","author":"C Eberle","year":"2010","unstructured":"Eberle C. Fetale Programmierung des Diabetes mellitus Typ 2: Intrauterine Wachstumsretardierung als Risikofaktor? MMW-Fortschritte Der Medizin. 2010;152:76\u201382. https:\/\/doi.org\/10.1007\/BF03373173.","journal-title":"MMW-Fortschritte Der Medizin"},{"key":"3975_CR22","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/975685","volume":"2012","author":"C Eberle","year":"2012","unstructured":"Eberle C, Ament C. Diabetic and metabolic programming: mechanisms altering the intrauterine milieu. ISRN Pediatr. 2012;2012: 975685. https:\/\/doi.org\/10.5402\/2012\/975685.","journal-title":"ISRN Pediatr"},{"key":"3975_CR23","doi-asserted-by":"publisher","unstructured":"Eberle C, Ament C. A combined in vivo and in silico model shows specific predictors of individual trans-generational diabetic programming. J Dev Orig Health Dis. 2020:1\u20138. https:\/\/doi.org\/10.1017\/S2040174420000471.","DOI":"10.1017\/S2040174420000471"},{"key":"3975_CR24","doi-asserted-by":"publisher","unstructured":"Eberle C, Stupin JH. 6.5 Perinatale Programmierung. In: Stupin J, Sch\u00e4fer-Graf U, Hummel M, editors. Diabetes in der Schwangerschaft: Praxisorientiertes Wissen zu Gestationsdiabetes, Diabetes mellitus Typ 1 und 2, MODY. 1st ed.; 2020. p. 242\u2013265. https:\/\/doi.org\/10.1515\/9783110569186-006.","DOI":"10.1515\/9783110569186-006"},{"key":"3975_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045361","volume":"7","author":"C Eberle","year":"2012","unstructured":"Eberle C, Merki E, Yamashita T, Johnson S, Armando AM, Quehenberger O, et al. Maternal immunization affects in utero programming of insulin resistance and type 2 diabetes. PLoS One. 2012;7: e45361. https:\/\/doi.org\/10.1371\/journal.pone.0045361.","journal-title":"PLoS One"},{"key":"3975_CR26","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1161\/01.RES.0000244003.08127.cc","volume":"99","author":"T Yamashita","year":"2006","unstructured":"Yamashita T, Freigang S, Eberle C, Pattison J, Gupta S, Napoli C, Palinski W. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res. 2006;99:e51-64. https:\/\/doi.org\/10.1161\/01.RES.0000244003.08127.cc.","journal-title":"Circ Res"},{"key":"3975_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","volume":"13","author":"MDJ Peters","year":"2015","unstructured":"Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141\u20136. https:\/\/doi.org\/10.1097\/XEB.0000000000000050.","journal-title":"Int J Evid Based Healthc"},{"key":"3975_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6: e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"key":"3975_CR29","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"Q-X Long","year":"2020","unstructured":"Long Q-X, Tang X-J, Shi Q-L, Li Q, Deng H-J, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200\u20134. https:\/\/doi.org\/10.1038\/s41591-020-0965-6.","journal-title":"Nat Med"},{"key":"3975_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91\u20135. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.017.","journal-title":"Int J Infect Dis"},{"key":"3975_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531\u20138. https:\/\/doi.org\/10.1007\/s00392-020-01626-9.","journal-title":"Clin Res Cardiol"},{"key":"3975_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3388","author":"A Al-Salameh","year":"2020","unstructured":"Al-Salameh A, Lanoix J-P, Bennis Y, Andrejak C, Brochot E, Deschasse G, et al. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes. Diabetes Metab Res Rev. 2020. https:\/\/doi.org\/10.1002\/dmrr.3388.","journal-title":"Diabetes Metab Res Rev"},{"key":"3975_CR33","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2337\/dc20-1192","volume":"43","author":"J Hartmann-Boyce","year":"2020","unstructured":"Hartmann-Boyce J, Morris E, Goyder C, Kinton J, Perring J, Nunan D, et al. Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters. Diabetes Care. 2020;43:1695\u2013703. https:\/\/doi.org\/10.2337\/dc20-1192.","journal-title":"Diabetes Care"},{"key":"3975_CR34","doi-asserted-by":"publisher","unstructured":"Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020:e3319. https:\/\/doi.org\/10.1002\/dmrr.3319.","DOI":"10.1002\/dmrr.3319"},{"key":"3975_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40618-020-01318-1","volume":"43","author":"T Filardi","year":"2020","unstructured":"Filardi T, Morano S. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? J Endocrinol Invest. 2020;43:1053\u201360. https:\/\/doi.org\/10.1007\/s40618-020-01318-1.","journal-title":"J Endocrinol Invest"},{"key":"3975_CR36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/dc20-0660","volume":"43","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care. 2020;43:1399\u2013407. https:\/\/doi.org\/10.2337\/dc20-0660.","journal-title":"Diabetes Care"},{"key":"3975_CR37","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmet.2018.08.003","volume":"28","author":"S Tsai","year":"2018","unstructured":"Tsai S, Clemente-Casares X, Zhou AC, Lei H, Ahn JJ, Chan YT, et al. Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection. Cell Metab. 2018;28:922-934.e4. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.003.","journal-title":"Cell Metab"},{"key":"3975_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1182\/blood-2007-11-121723","volume":"112","author":"ME Stegenga","year":"2008","unstructured":"Stegenga ME, van der Crabben SN, Bl\u00fcmer RME, Levi M, Meijers JCM, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008;112:82\u20139. https:\/\/doi.org\/10.1182\/blood-2007-11-121723.","journal-title":"Blood"},{"key":"3975_CR39","first-page":"22","volume":"117","author":"RD Gerste","year":"2020","unstructured":"Gerste RD. Thrombose-Pathogenese: Endotheldysfunktion bei COVID-19. Dtsch Arztebl. 2020;117:22\u20133.","journal-title":"Dtsch Arztebl"},{"key":"3975_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09573-6","author":"WS Azar","year":"2020","unstructured":"Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, Eid AA. COVID-19 and diabetes mellitus: how one pandemic worsens the other. Rev Endocr Metab Disord. 2020. https:\/\/doi.org\/10.1007\/s11154-020-09573-6.","journal-title":"Rev Endocr Metab Disord"},{"key":"3975_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.mayocp.2020.04.006","volume":"95","author":"J Xie","year":"2020","unstructured":"Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc. 2020;95:1138\u201347. https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.006.","journal-title":"Mayo Clin Proc"},{"issue":"370","key":"3975_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3320","volume":"2020","author":"J Allotey","year":"2019","unstructured":"Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease, , et al. in pregnancy: living systematic review and meta-analysis. BMJ (Clinical research ed). 2019;2020(370): m3320. https:\/\/doi.org\/10.1136\/bmj.m3320.","journal-title":"BMJ (Clinical research ed)"},{"key":"3975_CR43","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.mayocp.2020.05.011","volume":"95","author":"K Narang","year":"2020","unstructured":"Narang K, Enninga EAL, Gunaratne, Madugodaralalage DSK, Ibirogba ER, Trad ATA, Elrefaei A, et al. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. Mayo Clin Proc. 2020;95:1750\u201365. https:\/\/doi.org\/10.1016\/j.mayocp.2020.05.011.","journal-title":"Mayo Clin Proc"},{"key":"3975_CR44","unstructured":"Morris E, et al. Coronavirus (COVID-19) Infection in Pregnancy: 1Information for healthcare professionals. 11th ed.; 24.07.2020."},{"key":"3975_CR45","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/aogs.13867","volume":"99","author":"M Zaigham","year":"2020","unstructured":"Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99:823\u20139. https:\/\/doi.org\/10.1111\/aogs.13867.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3975_CR46","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0901-SA","author":"DA Schwartz","year":"2020","unstructured":"Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 2020. https:\/\/doi.org\/10.5858\/arpa.2020-0901-SA.","journal-title":"Arch Pathol Lab Med"},{"key":"3975_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.02.028","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.028.","journal-title":"J Infect"},{"key":"3975_CR48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMc2018688","volume":"383","author":"F Rubino","year":"2020","unstructured":"Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, et al. New-Onset Diabetes in Covid-19. N Engl J Med. 2020;383:789\u201390. https:\/\/doi.org\/10.1056\/NEJMc2018688.","journal-title":"N Engl J Med"},{"key":"3975_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108088","author":"R Pal","year":"2020","unstructured":"Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Res Clin Pract. 2020. https:\/\/doi.org\/10.1016\/j.diabres.2020.108088.","journal-title":"Diabetes Res Clin Pract"},{"key":"3975_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.arcmed.2020.03.011","volume":"51","author":"AE Gracia-Ramos","year":"2020","unstructured":"Gracia-Ramos AE. Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection? Arch Med Res. 2020;51:345\u20136. https:\/\/doi.org\/10.1016\/j.arcmed.2020.03.011.","journal-title":"Arch Med Res"},{"key":"3975_CR51","doi-asserted-by":"publisher","unstructured":"Hecht JL, Quade B, Deshpande V, Mino-Kenudson M, Ting DT, Desai N, et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Modern Pathol. 2020. https:\/\/doi.org\/10.1038\/s41379-020-0639-4.","DOI":"10.1038\/s41379-020-0639-4"},{"key":"3975_CR52","doi-asserted-by":"publisher","unstructured":"Ferraiolo A, Barra F, Kratochwila C, Paudice M, Vellone VG, Godano E, et al. Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19. Medicina (Kaunas, Lithuania) 2020. https:\/\/doi.org\/10.3390\/medicina56060306.","DOI":"10.3390\/medicina56060306"},{"key":"3975_CR53","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1055\/s-0040-1710050","volume":"37","author":"MC Alzamora","year":"2020","unstructured":"Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during Pregnancy and Possible Vertical Transmission. Am J Perinatol. 2020;37:861\u20135. https:\/\/doi.org\/10.1055\/s-0040-1710050.","journal-title":"Am J Perinatol"},{"key":"3975_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100133","volume":"2","author":"CA Penfield","year":"2020","unstructured":"Penfield CA, Brubaker SG, Limaye MA, Lighter J, Ratner AJ, Thomas KM, et al. Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples. Am J Obstet Gynecol MFM. 2020;2: 100133. https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100133.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"3975_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0002-9378(98)70254-6","volume":"179","author":"GP Sacks","year":"1998","unstructured":"Sacks GP, Studena K, Sargent IL, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80\u20136. https:\/\/doi.org\/10.1016\/s0002-9378(98)70254-6.","journal-title":"Am J Obstet Gynecol"},{"key":"3975_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1967","author":"Z-Y Wei","year":"2020","unstructured":"Wei Z-Y, Geng Y-J, Huang J, Qian H-Y. Pathogenesis and management of myocardial injury in coronavirus disease 2019. Eur J Heart Fail. 2020. https:\/\/doi.org\/10.1002\/ejhf.1967.","journal-title":"Eur J Heart Fail"},{"key":"3975_CR57","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.dsx.2020.04.049","volume":"14","author":"R Pal","year":"2020","unstructured":"Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14:513\u20137. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.049.","journal-title":"Diabetes Metab Syndr"},{"key":"3975_CR58","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1210\/jc.2018-01168","volume":"104","author":"A Iqbal","year":"2019","unstructured":"Iqbal A, Prince LR, Novodvorsky P, Bernjak A, Thomas MR, Birch L, et al. Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans. J Clin Endocrinol Metab. 2019;104:1187\u201399. https:\/\/doi.org\/10.1210\/jc.2018-01168.","journal-title":"J Clin Endocrinol Metab"},{"key":"3975_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103122","volume":"139","author":"H Liu","year":"2020","unstructured":"Liu H, Wang L-L, Zhao S-J, Kwak-Kim J, Mor G, Liao A-H. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139: 103122. https:\/\/doi.org\/10.1016\/j.jri.2020.103122.","journal-title":"J Reprod Immunol"},{"key":"3975_CR60","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4081\/cp.2020.1271","volume":"10","author":"A Cavezzi","year":"2020","unstructured":"Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020;10:1271. https:\/\/doi.org\/10.4081\/cp.2020.1271.","journal-title":"Clin Pract"},{"key":"3975_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/SJI.12918","volume":"92","author":"AM Abbas","year":"2020","unstructured":"Abbas AM, Ahmed OA, Shaltout AS. COVID-19 and maternal pre-eclampsia: A synopsis. Scand J Immunol. 2020;92: e12918. https:\/\/doi.org\/10.1111\/SJI.12918.","journal-title":"Scand J Immunol"},{"key":"3975_CR62","doi-asserted-by":"publisher","unstructured":"Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis, and new-onset Diabetes: might we envisage any cause-effect relationships among them? Diabetes Obes Metab. 2020. https:\/\/doi.org\/10.1111\/dom.14170.","DOI":"10.1111\/dom.14170"},{"key":"3975_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","volume":"47","author":"J-K Yang","year":"2010","unstructured":"Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193\u20139. https:\/\/doi.org\/10.1007\/s00592-009-0109-4.","journal-title":"Acta Diabetol"},{"key":"3975_CR64","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0301-2115(03)00174-X","volume":"110","author":"G Braems","year":"2003","unstructured":"Braems G. Fetal hypoxemia on a molecular level: adaptive changes in the hypothalamic\u2013pituitary\u2013adrenal (HPA) axis and the lungs. Eur J Obstet Gynecol Reprod Biol. 2003;110:S63\u20139. https:\/\/doi.org\/10.1016\/S0301-2115(03)00174-X.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3975_CR65","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1038\/s41467-020-17436-6","volume":"11","author":"AJ Vivanti","year":"2020","unstructured":"Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11:3572. https:\/\/doi.org\/10.1038\/s41467-020-17436-6.","journal-title":"Nat Commun"},{"key":"3975_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102951","volume":"59","author":"F Facchetti","year":"2020","unstructured":"Facchetti F, Bugatti M, Drera E, Tripodo C, Sartori E, Cancila V, et al. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta. EBioMedicine. 2020;59: 102951. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102951.","journal-title":"EBioMedicine"},{"key":"3975_CR67","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s00125-020-05164-x","volume":"63","author":"P Katulanda","year":"2020","unstructured":"Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, et al. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia. 2020;63:1440\u201352. https:\/\/doi.org\/10.1007\/s00125-020-05164-x.","journal-title":"Diabetologia"},{"key":"3975_CR68","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2337\/dci20-0026","volume":"43","author":"HD McIntyre","year":"2020","unstructured":"McIntyre HD, Moses RG. The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care. 2020;43:1433\u20134. https:\/\/doi.org\/10.2337\/dci20-0026.","journal-title":"Diabetes Care"},{"key":"3975_CR69","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.dsx.2020.06.030","volume":"14","author":"S Nouhjah","year":"2020","unstructured":"Nouhjah S, Jahanfar S, Shahbazian H. Temporary changes in clinical guidelines of gestational diabetes screening and management during COVID-19 outbreak: A narrative review. Diabetes Metab Syndr. 2020;14:939\u201342. https:\/\/doi.org\/10.1016\/j.dsx.2020.06.030.","journal-title":"Diabetes Metab Syndr"},{"key":"3975_CR70","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/medicina57040381","volume":"57","author":"AM Panaitescu","year":"2021","unstructured":"Panaitescu AM, Ciobanu AM, Popa M, Duta I, Gica N, Peltecu G, Veduta A. Screening for Gestational Diabetes during the COVID-19 Pandemic\u2014Current Recommendations and Their Consequences. Medicina. 2021;57:381. https:\/\/doi.org\/10.3390\/medicina57040381.","journal-title":"Medicina"},{"key":"3975_CR71","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/1471-0528.16482","volume":"128","author":"Y van-de-l\u2019Isle","year":"2021","unstructured":"van-de-l\u2019Isle Y, Steer PJ, Watt Coote I, Cauldwell M. Impact of changes to national UK Guidance on testing for gestational diabetes screening during a pandemic: a single-centre observational study. BJOG. 2021;128:917\u201320. https:\/\/doi.org\/10.1111\/1471-0528.16482.","journal-title":"BJOG"},{"key":"3975_CR72","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.dsx.2021.01.021","volume":"15","author":"S Zhu","year":"2021","unstructured":"Zhu S, Meehan T, Veerasingham M, Sivanesan K. COVID-19 pandemic gestational diabetes screening guidelines: A retrospective study in Australian women. Diabetes Metab Syndr. 2021;15:391\u20135. https:\/\/doi.org\/10.1016\/j.dsx.2021.01.021.","journal-title":"Diabetes Metab Syndr"},{"key":"3975_CR73","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/1932296820929719","volume":"14","author":"DT Ahn","year":"2020","unstructured":"Ahn DT. The COVID-19 Pandemic: A \u201cTech\u201d-tonic Shift Toward Virtual Diabetes Care. J Diabetes Sci Technol. 2020;14:708\u20139. https:\/\/doi.org\/10.1177\/1932296820929719.","journal-title":"J Diabetes Sci Technol"},{"key":"3975_CR74","unstructured":"German Diabetes Association (DDG). Aus der Krise lernen: Digitalisierung und Telemedizin nutzen und Versorgung von Patienten mit Diabetes mellitus verbessern \u2013 auch nach der Corona-Pandemie. 2020. https:\/\/www.deutsche-diabetes-gesellschaft.de\/pressekonferenzen\/endstation-notstand-wie-wir-die-weichen-fuer-eine-gute-diabetesversorgung-von-morgen-stellen-1. Accessed 31 Aug 2020."},{"key":"3975_CR75","doi-asserted-by":"publisher","unstructured":"Farooqi MH. Tele-Management of Diabetes in the Post-COVID-19 Era. Dubai Diabetes Endocrinol J. 2020:1\u20133. https:\/\/doi.org\/10.1159\/000510273.","DOI":"10.1159\/000510273"},{"key":"3975_CR76","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1055\/s-0040-1712121","volume":"37","author":"A Aziz","year":"2020","unstructured":"Aziz A, Zork N, Aubey JJ, Baptiste CD, D\u2019alton ME, Emeruwa UN, et al. Telehealth for High-Risk Pregnancies in the Setting of the COVID-19 Pandemic. Am J Perinatol. 2020;37:800\u20138. https:\/\/doi.org\/10.1055\/s-0040-1712121.","journal-title":"Am J Perinatol"},{"key":"3975_CR77","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/JOD.JOD_44_20","volume":"11","author":"M Simon","year":"2020","unstructured":"Simon M, Sarkar N, Kumaran S, Chittake A, Purandare V, Unnikrishnan A. Telemedicine for the initial management of newly diagnosed gestational diabetes in the pandemic period: A report of three case studies. J Diabetol. 2020;11:144. https:\/\/doi.org\/10.4103\/JOD.JOD_44_20.","journal-title":"J Diabetol"},{"key":"3975_CR78","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6556","volume":"18","author":"W-K Ming","year":"2016","unstructured":"Ming W-K, Mackillop LH, Farmer AJ, Loerup L, Bartlett K, Levy JC, et al. Telemedicine Technologies for Diabetes in Pregnancy: A Systematic Review and Meta-Analysis. J Med Internet Res. 2016;18: e290. https:\/\/doi.org\/10.2196\/jmir.6556.","journal-title":"J Med Internet Res"},{"key":"3975_CR79","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.dsx.2020.08.004","volume":"14","author":"F Moradi","year":"2020","unstructured":"Moradi F, Ghadiri-Anari A, Enjezab B. COVID-19 and self-care strategies for women with gestational diabetes mellitus. Diabetes Metab Syndr. 2020;14:1535\u20139. https:\/\/doi.org\/10.1016\/j.dsx.2020.08.004.","journal-title":"Diabetes Metab Syndr"},{"key":"3975_CR80","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688129","author":"C Eberle","year":"2019","unstructured":"Eberle C, Ament C. Digitale Diabetologie \u2013 Eine quantitative Analyse diabetesspezifischer mHealth-Apps. Diabetes Stoffwechsel. 2019. https:\/\/doi.org\/10.1055\/s-0039-1688129.","journal-title":"Diabetes Stoffwechsel"},{"key":"3975_CR81","doi-asserted-by":"publisher","unstructured":"Eberle C. 8. Einsatz neuer Technologien in Diagnostik und Therapie: Diabetes-Smartphone-Apps. In: Stupin J, Sch\u00e4fer-Graf U, Hummel M, editors. Diabetes in der Schwangerschaft: Praxisorientiertes Wissen zu Gestationsdiabetes, Diabetes mellitus Typ 1 und 2, MODY. 1st ed.; 2020. p.\u00a0311\u2013314. https:\/\/doi.org\/10.1515\/9783110569186-008.","DOI":"10.1515\/9783110569186-008"},{"key":"3975_CR82","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1055\/s-0037-1601701","volume":"12","author":"C Eberle","year":"2017","unstructured":"Eberle C, Ament C. Diabetes & Schwangerschaft 4.0 \u2013 Individualisierte Nutzungsanalyse von mHealth-Apps. Diabetologie Stoffwechsel. 2017;12:S1\u201384. https:\/\/doi.org\/10.1055\/s-0037-1601701.","journal-title":"Diabetologie Stoffwechsel"},{"key":"3975_CR83","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688270","author":"C Eberle","year":"2019","unstructured":"Eberle C, Ament C. Schwangerschaft und Digitalisierung \u2013 Individualisierte Nutzungsanalyse von Schwangerschafts- und GDM-Apps. Diabetes Stoffwechsel. 2019. https:\/\/doi.org\/10.1055\/s-0039-1688270.","journal-title":"Diabetes Stoffwechsel"},{"key":"3975_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108396","volume":"169","author":"L Albert","year":"2020","unstructured":"Albert L, Capel I, Garc\u00eda-S\u00e1ez G, Mart\u00edn-Redondo P, Hernando ME, Rigla M. Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie) during the COVID-19 pandemic: Much more than just telemedicine. Diabetes Res Clin Pract. 2020;169: 108396. https:\/\/doi.org\/10.1016\/j.diabres.2020.108396.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03975-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-03975-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03975-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T23:12:27Z","timestamp":1629501147000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03975-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3975"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03975-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"573"}}